Franklin Resources’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$250K Sell
108,399
-7,839
-7% -$18.1K ﹤0.01% 2629
2025
Q1
$162K Buy
+116,238
New +$162K ﹤0.01% 2728
2024
Q4
Sell
-100,795
Closed -$201K 3018
2024
Q3
$201K Buy
+100,795
New +$201K ﹤0.01% 2629
2023
Q4
Sell
-810,840
Closed -$2.56M 2713
2023
Q3
$2.56M Hold
810,840
﹤0.01% 1302
2023
Q2
$536K Hold
810,840
﹤0.01% 1931
2023
Q1
$647K Sell
810,840
-229
-0% -$183 ﹤0.01% 1613
2022
Q4
$1.83M Hold
811,069
﹤0.01% 1386
2022
Q3
$1.57M Hold
811,069
﹤0.01% 1414
2022
Q2
$3.02M Sell
811,069
-489,599
-38% -$1.82M ﹤0.01% 1243
2022
Q1
$8.48M Sell
1,300,668
-7,865
-0.6% -$51.3K ﹤0.01% 1055
2021
Q4
$15.2M Sell
1,308,533
-1,677
-0.1% -$19.5K 0.01% 958
2021
Q3
$24.4M Buy
1,310,210
+4,364
+0.3% +$81.3K 0.01% 845
2021
Q2
$27.7M Buy
1,305,846
+186,677
+17% +$3.96M 0.01% 791
2021
Q1
$22.7M Buy
1,119,169
+319,640
+40% +$6.49M 0.01% 807
2020
Q4
$21.2M Sell
799,529
-991
-0.1% -$26.3K 0.01% 801
2020
Q3
$17.9M Buy
+800,520
New +$17.9M 0.01% 794